Stockreport

Immune Pharmaceuticals Announces Positive Preclinical Results in Asthma

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF A broad anti-inflammatory effect observed FORT LEE, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), [Read more]